PERSIVIA - Key Persons
Ammar has over 20 years of executive leadership experience in growing, scaling and selling venture- backed and private equity-backed entities in various sectors. He was CFO/ COO at NaviNet and led it to a successful exit. He has also led exits as CFO for Cayan and TNS Media. He is a graduate of McGill University.
Dr. Fauzia Khan has deep expertise in algorithm design, knowledge acquisition and engineering as well as data mining and leveraging these capabilities to improve outcomes. She is the author, editor and primary visionary of the "Guide to Diagnostic Medicine", Lippincott Williams & Wilkins, 2002. Prior to Persivia, Dr. Khan was an attending physician, and program director of Informatics, Department of Pathology at UMass Memorial Health Center, and an Assistant Clinical Professor and Director of Clinical Pathology Residency Program at UMass Medical School.
Dr. Mansoor Khan is a 20 year veteran of the software and healthcare industries. He is a serial entrepreneur who has been developing advanced technologies and cutting edge software since the mid 90s. Over the years he has led teams that have developed technology and applications for Disease Surveillance, Artificial Intelligence, Quality Management, Analytics, Care Management and Cost and Utilization Management. These efforts have won numerous awards over the years including best Decision Support System for ACOs (Blackbook) and Top 100 AI companies. Previously Dr. Khan founded and had successful exits from KeyCommerce (1997 - 2004), DiagnosisOne (2005 - 2012) and was CEO of Alere Analytics (2012 - 2015).
Job Titles:
- Vice President, Implementation and Customer Service
- VP, Implementation & CS
Giri is driven by a passion for simplifying the end-user experience and for finding superior solutions to perplexing, complex challenges. He has more than 20 years' experience in EMR/PM, revenue cycle, patient engagement, population health management, clinical trials/outcomes research and clearinghouse/payer EDI transactions. Giri is a tireless leader who first envisions the desired results and then collaboratively engages the team to develop high-quality solutions to ensure highly satisfied clients.
Muhammad is a growth-focused and detail-oriented professional with more than 20 years of experience delivering enterprise-scale IT solutions. He applies deep knowledge of the Health IT and telecommunications industry standards & data formats to deliver best-in-class software development, enterprise architecture, and service. With Muhammed at the helm of IT, high performance distributed systems are designed and developed for scalability, security, and resiliency.
Job Titles:
- Vice President, Business Development
- VP, Business Development
An adept communicator and accomplished team builder, Roger has over 25 years of health care experience in multiple delivery channels encompassing the end-to-end healthcare ecosystem. He has significant breadth and in-depth knowledge of payer, provider, hospital and physician group environments. Roger regularly consults with companies concerning clinical decision support, value-based care, population health and artificial intelligence.
Job Titles:
- Chief Executive Officer, Co - Founder and Chairman at LumiraDx
Mr. Zwanziger is one of LumiraDx's co-founders and has served as Chief Executive Officer and Chairman of the LumiraDx group, since its inception in November 2014. He has served as a member of LumiraDx's board of directors since September 2016 when the company was established as the parent entity of group. Mr. Zwanziger brings strategic vision, leadership, extensive business and operating experience and deep knowledge of the industry to the company. From 2001 to 2014, Mr. Zwanziger served as Chairman, Chief Executive Officer and President of Alere Inc., a diagnostic test manufacturer, or Alere. From 1992 to 2001, he served as Chairman, Chief Executive Officer and President of Alere's predecessor company, Inverness Medical Technology Inc., or Inverness, until the company was acquired by Johnson & Johnson. From 1981 to 1991, he served as Chairman and Chief Executive Officer of MediSense, a medical device company. Mr. Zwanziger served as a director of AMAG Pharmaceuticals Inc. from November 2006 to December 2011 and currently serves on the board of directors of several private companies. Mr. Zwanziger received a B.S. in civil engineering from Imperial College London and an M.B.A from Harvard Business School.
Job Titles:
- Client Solution Architect
Shardul leverages his clinical background and in-depth knowledge of Persivia's CareSpace platform to delve into customer needs and deliver relevant product demonstrations. After the sale, he helps ensure the client has a seamless on-boarding experience by mapping out their current workflows in the CareSpace Platform and providing thorough training.
Job Titles:
- Vice President, Client Services
- VP, Client Services
With an impressive 25 years in the healthcare industry, Sharon has been responsible for customer accounts and customized education and collaboration to improve hospital quality and patient outcomes. Prior to Persivia, Sharon was the Director of Quality, Scotland Health Care System affiliated with Carolinas Healthcare System in North Carolina. She was responsible for the hospital's quality and performance improvement program and implemented Lean Six Sigma to strategically identify and standardize hospital-based, organizational priorities.
Job Titles:
- Founder
- Managing Partner
- Founder and Managing Partner of Petrichor
Tadd S. Wessel is the founder and Managing Partner of Petrichor. Mr. Wessel was formerly a Managing Director at OrbiMed Advisors, where he led the build out of the healthcare special situations and structured finance business. Prior to OrbiMed, Mr. Wessel was a Vice President in the Drawbridge Special Opportunities Fund at Fortress Investment Group, focused on healthcare investments. Mr. Wessel began his career in investment banking at Robertson Stephens, where he worked in the life sciences group. Mr. Wessel holds an A.B. in Biology from Princeton University.